ZA977402B - A DNA and a method of preparing a protein thereby - Google Patents

A DNA and a method of preparing a protein thereby

Info

Publication number
ZA977402B
ZA977402B ZA977402A ZA977402A ZA977402B ZA 977402 B ZA977402 B ZA 977402B ZA 977402 A ZA977402 A ZA 977402A ZA 977402 A ZA977402 A ZA 977402A ZA 977402 B ZA977402 B ZA 977402B
Authority
ZA
South Africa
Prior art keywords
dna
protein
preparing
Prior art date
Application number
ZA977402A
Other languages
English (en)
Inventor
Nobuaki Nakagawa
Hisataka Yasuda
Tomonori Morinaga
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of ZA977402B publication Critical patent/ZA977402B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA977402A 1996-08-19 1997-08-18 A DNA and a method of preparing a protein thereby ZA977402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法

Publications (1)

Publication Number Publication Date
ZA977402B true ZA977402B (en) 1999-02-18

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA977402A ZA977402B (en) 1996-08-19 1997-08-18 A DNA and a method of preparing a protein thereby

Country Status (12)

Country Link
EP (1) EP0874045A1 (enExample)
JP (1) JPH1057071A (enExample)
KR (1) KR20000064276A (enExample)
CN (1) CN1198776A (enExample)
AU (1) AU718458B2 (enExample)
CA (1) CA2235148A1 (enExample)
FI (1) FI980853L (enExample)
HU (1) HUP0001837A3 (enExample)
NO (1) NO981748L (enExample)
NZ (1) NZ330400A (enExample)
WO (1) WO1998007840A1 (enExample)
ZA (1) ZA977402B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1998028424A2 (en) 1996-12-23 1998-07-02 Immunex Corporation Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
ATE328006T1 (de) 1997-04-15 2006-06-15 Sankyo Co Neues protein und verfahren zu dessen herstellung
PL190092B1 (pl) 1997-04-16 2005-10-31 Amgen Inc Proteiny wiążące osteoprotegerynę oraz ich receptory
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
RU2203497C2 (ru) 1997-09-24 2003-04-27 Санкио Компани Лимитед Способ диагностики метаболических костных заболеваний
JP2002514418A (ja) 1998-05-14 2002-05-21 イミュネックス・コーポレーション 破骨細胞活性の阻害方法
AU755422B2 (en) 1998-10-28 2002-12-12 Sankyo Company Limited Remedies for bone metabolic errors
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
DE60235418D1 (de) 2001-04-03 2010-04-01 Nestle Sa Osteoprotegerin in Milch
AU2002309647C1 (en) 2001-05-25 2008-09-11 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
EP1494714A4 (en) 2002-04-05 2008-03-05 Amgen Inc HUMAN ANTI-OPGL NEUTRALIZING ANTIBODIES AS SELECTIVE OPGL PATH HEMMER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
FI980853A7 (fi) 1998-06-15
EP0874045A1 (en) 1998-10-28
FI980853L (fi) 1998-06-15
HUP0001837A3 (en) 2002-09-30
NZ330400A (en) 1999-05-28
EP0874045A4 (enExample) 1998-11-18
HUP0001837A2 (hu) 2000-09-28
MX9803086A (es) 1998-11-29
CA2235148A1 (en) 1998-02-26
FI980853A0 (fi) 1998-04-17
AU718458B2 (en) 2000-04-13
NO981748L (no) 1998-06-18
JPH1057071A (ja) 1998-03-03
CN1198776A (zh) 1998-11-11
NO981748D0 (no) 1998-04-17
WO1998007840A1 (fr) 1998-02-26
KR20000064276A (ko) 2000-11-06
AU3866197A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
PL331285A1 (en) Erythromycins and method of preparing them
GB9626815D0 (en) Method of sequencing DNA
GB9620209D0 (en) Method of sequencing DNA
EP0725145A4 (en) PROTEIN MODIFICATION PROCESS
EP1027450A4 (en) METHOD FOR DNA SHUFFLING
PL339268A1 (en) Rapid marking-out method and system
EP0971061A4 (en) SEWING PROCESS AND DEVICE
AU3927897A (en) DNA microwell device and method
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
SG105506A1 (en) Gene sequencer and methods
GB2311192B (en) Data-transmitter-receiver and method of operation
ZA981975B (en) A method and system of identification
ZA977402B (en) A DNA and a method of preparing a protein thereby
HUP0003206A3 (en) Methods of preparing and purifying 9-nitro-20-camptothecin
IL118375A0 (en) Rhesus OB protein and DNA
AU6565896A (en) DNA sequencing method and DNA sample preparation method
EP0699475A4 (en) DEFROSTING MATERIAL AND DEFROSTING METHOD
AU5369396A (en) Rest protein and dna
AU5224998A (en) Hair-curler and method for setting hair
GB9724270D0 (en) Methods and means for mutagenesis of dna
AU4289896A (en) Artificial nail and method for making same
GB9512092D0 (en) Proteins and nucleic acids
GB9310227D0 (en) Protein and dna
GB9706078D0 (en) Screening method and proteins and dna identified thereby
GB9502480D0 (en) DNA and protein sequences